The effect of trimethoprim on the activity of sulfonamides and antibiotics in experimental infections.
D000284:Administration, Oral; D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy*; D004357:Drug Synergism; D004927:Escherichia coli Infections / Q000188:drug therapy; D006192:Haemophilus Infections / Q000188:drug therapy; D007710:Klebsiella Infections / Q000188:drug therapy; D002955:Leucovorin / Q000494:pharmacology; D051379:Mice; D008826:Microbial Sensitivity Tests; D011008:Pneumococcal Infections / Q000188:drug therapy; D011512:Proteus Infections / Q000188:drug therapy; D011552:Pseudomonas Infections / Q000188:drug therapy; D011550:Pseudomonas aeruginosa; D012480:Salmonella Infections / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D013449:Sulfonamides / Q000008:administration & dosage* / Q000627:therapeutic use; D013936:Thymidine / Q000494:pharmacology; D014295:Trimethoprim / Q000008:administration & dosage* / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D013449:Sulfonamides; D014295:Trimethoprim; D002955:Leucovorin; D013936:Thymidine